Litcius/Paper detail

Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis

Daisuke Kobayashi, Yasuhiro Kodera, Ryoji Fukushima, Masaru Morita, Sachio Fushida, Naoyuki Yamashita, Kozo Yoshikawa, Shugo Ueda, Hiroshi Yabusaki, Tetsuya Kusumoto, Takaaki Arigami, Akio Hidemura, Takeshi Omori, Hironori Yamaguchi, Yasuo Hirono, Yasushi Tsuji, Jeong Ho Moon, Toshihiko Tomita, Hiroshi Imamura, Koki Nakanishi, Dai Shimizu, Akihiro Hirakawa, Hironori Ishigami, Joji Kitayama

2023Annals of Surgical Oncology19 citationsDOI

Topics & Concepts

MedicinePaclitaxelNeutropeniaRegimenInternal medicineGastroenterologyClinical endpointSurvival rateOncologySurgeryCisplatinCancerChemotherapyClinical trialIntraperitoneal and Appendiceal MalignanciesGastric Cancer Management and OutcomesGastrointestinal Tumor Research and Treatment
Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis | Litcius